Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

Authors

Mitch Dowsett, Royal Marsden Hospital
Cynthia X. Ma, Washington University School of Medicine in St. Louis
et al.

Journal

NPJ Breast Cancer

Publication Date

2020

Volume

6

Issue

1

First Page

21

Document Type

Open Access Publication

DOI

10.1038/s41523-020-0168-9

Rights and Permissions

Dowsett, M., Ellis, M. J., Dixon, J. M., Gluz, O., Robertson, J., Kates, R., . . . Harbeck, N. (2020). Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic. Npj Breast Cancer, 6(1) doi:10.1038/s41523-020-0168-9 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Dowsett, Mitch; Ma, Cynthia X.; and al., et, "Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic." NPJ Breast Cancer. 6, 1. 21 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9432